CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 36 enrolled
Drug / intervention
revascularizationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01133054
NCT01133054Phase 4Completed
CompareCT.gov

Physiologic Evaluation of Anomalous Right Coronary Artery Stenosis

Seoul National University Hospital·interventional·Posted May 28, 2010·Updated Dec 3, 2013

In Brief

A Phase 4 clinical trial evaluating revascularization for Coronary Vessel Anomalies. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The anomalous origin of right coronary artery (RCA) is a rare coronary anomaly. Recently, the detection of this anomaly has been more frequent as the use of cardiac multidetector computed tomography has become more popular. It can cause myocardial ischemia, syncope and sudden cardiac death. Surgical repair is generally recommended for symptomatic patients. However, there is controversy concerning the proper evaluation and treatment strategy for patients without documented myocardial ischemia. The stenotic lesion of anomalous origin of RCA will be assessed by fractional flow reserve (FFR).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Vessel Anomalies
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 28, 2010
Enrollment StartAug 1, 2009
Primary CompletionDec 1, 2013
TodayJul 1, 2026
Enrollment to primary: 4.3 yearsPosted 16.1 years ago

Interventions

revascularizationprocedure

surgery or stenting